enVVeno Medical
NVNO
30 hedge funds and large institutions have $9.61M invested in enVVeno Medical in 2025 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 7 increasing their positions, 11 reducing their positions, and 6 closing their positions.
102% more call options, than puts
Call options by funds: $170K | Put options by funds: $84K
0.1% less ownership
Funds ownership: 0.69% → 0.59% (-0.1%)
12% less funds holding
Funds holding: 34 → 30 (-4)
25% less capital invested
Capital invested by funds: $12.9M → $9.61M (-$3.27M)
36% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 11
67% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DIG
Dauntless Investment Group
Etna,
New Hampshire
|
+$226K |
| 2 |
WIM
Westside Investment Management
Santa Monica,
California
|
+$172K |
| 3 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$96.9K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$49.6K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$37.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$632K |
| 2 |
ACM
Altium Capital Management
New York
|
-$594K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$254K |
| 4 |
JP Morgan Chase
New York
|
-$241K |
| 5 |
Morgan Stanley
New York
|
-$194K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $4.22K | -$16.4K | -147 | -76% |
|
27
CIBC Private Wealth Group
Atlanta,
Georgia
| $1.82K | – | – | – |
|
28
RhumbLine Advisers
Boston,
Massachusetts
| $1.64K | – | – | – |
|
29
Osaic Holdings
Scottsdale,
Arizona
| $657 | -$1.11K | -10 | -59% |
|
30
Bank of America
Charlotte,
North Carolina
| $394 | – | – | – |
|
|
SS
31
SBI Securities
Tokyo,
Japan
| $16 | – | – | – |
|
|
32
Alyeska Investment Group
Chicago,
Illinois
| – | -$632K | -5,977 | Closed |
|
33
Marshall Wace
London,
United Kingdom
| – | -$147K | -1,395 | Closed |
|
|
QC
34
Quadrature Capital
London,
United Kingdom
| – | -$119K | -1,121 | Closed |
|
|
VF
35
Virtu Financial
New York
| – | -$86K | -815 | Closed |
|
36
National Bank of Canada
Montreal,
Quebec, Canada
| – | -$60.4K | -571 | Closed |
|
37
Jane Street
New York
| – | -$55.9K | -529 | Closed |
|
NVNO Hedge Fund Activity: Q1 2025 in Review
30 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in enVVeno Medical (NVNO) for Q1 2025, worth a combined $9.61M — down 25% from $12.9M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of NVNO and 2 opened new positions — a net loss of 4 holders — while 11 trimmed existing stakes and 7 added.
The largest buyer was Dauntless Investment Group, opening a new position worth an estimated $226K. The largest seller was Alyeska Investment Group, exiting entirely with an estimated $632K sold.
- 30 institutional investors held enVVeno Medical (NVNO) as of Q1 2025, down from 34 in Q4 2024.
- Funds reported $9.61M of enVVeno Medical stock for Q1 2025, down 25% quarter-over-quarter.
- 2 funds opened new enVVeno Medical positions in Q1 2025 and 6 closed out, a net change of -4 holders.
- The largest enVVeno Medical buyer in Q1 2025 was Dauntless Investment Group, an estimated $226K added.
- The largest enVVeno Medical seller in Q1 2025 was Alyeska Investment Group, an estimated $632K sold.
Based on aggregated 13F filings for Q1 2025.